Last month, PharmaVOICE told its readers about some of the remarkable volunteer activities of seven pharma and biotech companies and their employees. This month, we discuss the commitment to communities of more life-sciences companies. Many companies have a long history of philanthropy. Novartis, for example, has established a number of foundations to support global philanthropy and commits to a community partnership day every year, in which affiliates from around the world take part in initiatives to support local communities. Many of the companies in this article have community days where employees are given time off to volunteer.
Volunteering is something employees at these companies feel passionate about and increasingly it’s being seen as an integral part of good corporate stewardship. In addition, forward-thinking and philanthropic companies understand that in a world where criticism is rife, community-mindedness has benefits for the company…
EMD Serono Inc., an affiliate of Merck KGaA, Darmstadt, Germany, integrates cutting-edge science with patient support systems to improve people’s lives. EMD Serono has a leadership position in fertility treatments and has strong market positions in neurodegenerative diseases, as well as in endocrinology. With a clear focus on the patient and a leadership presence in the biopharmaceutical industry, EMD Serono has more than 850 employees around the country and fully integrated commercial, clinical, and research operations in the company’s home state of Massachusetts. For more information, please visit emdserono.com.
GlaxoSmithKline, Middlesex, United Kingdom, with operations based in the United States, is a research-based pharmaceutical company with treatments for a variety of conditions and more than 25 vaccines to protect against many illnesses. GSK also is committed to investing in health and education programs that aim to bring sustainable improvements to underserved people in the developed and developing world. For more information, visit gsk.com.
Invitrogen, Carlsbad, Calif., provides life-science technologies for disease research, drug discovery, and commercial bioproduction to pharmaceutical and biotechnology companies, as well as academic and government research institutions. Invitrogen’s R&D efforts are focused on innovation in all major areas of biological discovery including functional genomics, proteomics, stem cells, cell therapy, and cell biology. For more information, visit invitrogen.com.
Sandoz, Holzkirchen, Germany is a Novartis company and global generics leader that develops, produces, and markets medicines that are no longer protected by patents. For more information, visit sandoz.com.
Solvay Pharmaceuticals, Marietta, Ga., is the U.S. subsidiary of a research-driven group of companies that constitute the global pharmaceutical business of the Solvay Group. The company seeks to fulfill carefully selected, unmet medical needs in the therapeutic areas of neuroscience, cardio-metabolic, influenza vaccines, gastroenterology, and men’s and women’s health. For more information, visit solvaypharmaceuticals-us.com.
Stiefel Laboratories, Coral Gables, Fla., is a specialized pharmaceutical company with a singular focus on the advancement of dermatology and skin care around the world. For more information, visit stiefel.com.
Wyeth, Madison, N.J., is a global leader in pharmaceuticals, consumer healthcare products, and animal healthcare products, with R&D programs focused on small molecules, vaccines, and biotechnology. For more information, visit wyeth.com.